{"Neurodegenerative": [0], "disorders": [1, 12], "are": [2, 20], "primarily": [3, 45], "characterized": [4], "by": [5, 115], "neuron": [6], "loss.": [7], "The": [8], "most": [9], "common": [10], "neurodegenerative": [11, 27], "include": [13], "Alzheimer\u2019s": [14], "and": [15, 96, 100, 123], "Parkinson\u2019s": [16, 94], "disease.": [17], "Although": [18], "there": [19], "several": [21], "medicines": [22], "currently": [23], "approved": [24], "for": [25, 77, 120], "managing": [26], "disorders,": [28], "a": [29], "large": [30], "majority": [31], "of": [32, 41, 51, 61, 66, 92, 111, 118, 125], "them": [33], "only": [34], "help": [35], "with": [36], "associated": [37], "symptoms.": [38], "This": [39, 86], "lack": [40], "pathogenesis-targeting": [42], "therapies": [43], "is": [44], "due": [46], "to": [47, 59], "the": [48, 52, 67, 84, 90, 108, 116, 121], "restrictive": [49], "effects": [50], "blood\u2013brain": [53], "barrier": [54], "(BBB),": [55], "which": [56], "keeps": [57], "close": [58], "99%": [60], "all": [62], "\u201cforeign": [63], "substances\u201d": [64], "out": [65], "brain.": [68, 85], "Since": [69], "their": [70, 101], "discovery,": [71], "nanoparticles": [72], "have": [73], "been": [74], "successfully": [75], "used": [76], "targeted": [78], "delivery": [79], "into": [80], "many": [81], "organs,": [82], "including": [83], "review": [87], "briefly": [88], "describes": [89], "pathophysiology": [91], "Alzheimer\u2019s,": [93], "disease,": [95], "amyotrophic": [97], "lateral": [98], "sclerosis,": [99], "current": [102], "management": [103], "approaches.": [104], "We": [105], "then": [106], "highlight": [107], "major": [109], "challenges": [110], "brain-drug": [112], "delivery,": [113], "followed": [114], "role": [117], "nanotherapeutics": [119], "diagnosis": [122], "treatment": [124], "various": [126], "neurological": [127], "disorders.": [128]}